Orexigen Therapeutics, Inc. News Headlines

Get OREX Alerts
*Delayed - data as of Jan. 23, 2015  -  Find a broker to begin trading OREX now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
Basic Chart Interactive Chart
Company Headlines Press Releases Market Stream
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Filtered By
Ordered By
Contrave Prescriptions Still Rising In A Down Week
12/22/2014 3:47:00 PM - Seeking Alpha

Orexigen - Contrave Script Numbers Remain Impressive
12/22/2014 3:31:00 PM - Seeking Alpha

Belviq Scripts Dip - Lack Of T.V. Ads Will Impact Next Numbers
12/22/2014 3:27:00 PM - Seeking Alpha

Orexigen Retreats After Positive News In Europe: 3 Things To Watch For
12/22/2014 3:18:00 PM - Seeking Alpha

Orexigen's Obesity Drug Mysimba Gets CHMP Nod - Analyst Blog
12/22/2014 6:10:00 AM - Investopedia

JAZZ Hits Right Note, ENTA's Purse Set To Fatten, AEZS Put On Notice
12/21/2014 11:36:00 PM - RTT News

New Obesity Drug Available Soon
12/21/2014 10:22:40 PM - Motley Fool

Seeking Alpha's Biotech Weekly: A Merck Purchase, Spectacular Auspex, And More
12/19/2014 4:00:00 PM - Seeking Alpha

Arena And Vivus Investors Need To Grasp Implications Of Orexigen
12/19/2014 2:22:00 PM - Seeking Alpha

Contrave Wins Approval Recommendation In Europe
12/19/2014 11:53:00 AM - Seeking Alpha

Pre-Market Most Active for Dec 19, 2014 : ALLY, BBRY, BP, AVNR, TNK, PBR, OREX, BHP, SDRL, QQQ, AAPL, IMGN
12/19/2014 8:39:55 AM - NASDAQ.com News

Health Care Sector Update for 12/19/2014: CRME, TEVA, OREX
12/19/2014 8:36:09 AM - MT Newswires

Orexigen: Mysimba Receives Positive CHMP Opinion Recommending Approval In EU
12/19/2014 7:56:00 AM - RTT News

4 Top Ranked Biotech Stocks that Beat the Market in 2014 - Analyst Blog
12/16/2014 11:26:00 AM - Investopedia

Low-Cost Contrave Fuels Anti-Obesity Drugs Recovery From Thanksgiving
12/16/2014 1:50:00 AM - Seeking Alpha

Why Should Investors Expect Physicians To Treat Obesity With Pharmacotherapy?
12/15/2014 10:30:00 AM - Seeking Alpha

Contrave Sales Continue To Impress
12/12/2014 4:26:00 PM - Seeking Alpha

Arena: Belviq Sales See Pleasant Rebound
12/12/2014 4:05:00 PM - Seeking Alpha

Assessing The Beginnings Of The Orexigen Launch Of Contrave
12/10/2014 1:09:00 PM - Seeking Alpha

Contrave Sales Are Driven By Reps And Discounts, Not Insurance (Yet)
12/9/2014 1:12:00 PM - Seeking Alpha

This Growing Concern Accounts For Nearly 500,000 Cancer Cases Each Year
12/7/2014 1:51:02 PM - Motley Fool

Will Diabetes Drugs Enter The Anti-Obesity Space?
12/7/2014 6:58:00 AM - Seeking Alpha

Orexigen Thera. To Present At Piper Jaffray Conference; Webcast At 12:30 PM ET
12/3/2014 11:30:00 AM - RTT News

Why Orexigen Therapeutics, Inc. Stock Rocketed 43% Higher in November
12/3/2014 8:36:03 AM - Motley Fool

Arena Pharmaceuticals: Belviq Sales Take A Modest Dip With Holiday
11/22/2014 2:51:00 PM - Seeking Alpha